 | • レポートコード：B-GIR08C0782 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、癌診断治療バイオマーカー技術プラットフォームの世界市場について調べ、まとめました。種類別セグメントは、タイプⅠ、タイプⅡ等、用途別セグメントは、等に区分しました。癌診断治療バイオマーカー技術プラットフォームの世界市場概観、企業動向、企業別癌診断治療バイオマーカー技術プラットフォームシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・癌診断治療バイオマーカー技術プラットフォームの市場概観 ・癌診断治療バイオマーカー技術プラットフォームの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・癌診断治療バイオマーカー技術プラットフォームの企業別販売動向、市場シェア、市場集中度、競争動向 ・癌診断治療バイオマーカー技術プラットフォームの世界市場規模 ・癌診断治療バイオマーカー技術プラットフォームの北米市場分析（アメリカ、カナダ、メキシコ等） ・癌診断治療バイオマーカー技術プラットフォームのアメリカ市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのカナダ市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのメキシコ市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・癌診断治療バイオマーカー技術プラットフォームのドイツ市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのイギリス市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのロシア市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・癌診断治療バイオマーカー技術プラットフォームの日本市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームの中国市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームの韓国市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームのインド市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームの東南アジア市場規模推移 ・癌診断治療バイオマーカー技術プラットフォームの南米市場分析（ブラジル、アルゼンチン等） ・癌診断治療バイオマーカー技術プラットフォームの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・癌診断治療バイオマーカー技術プラットフォームの種類別分析/販売量、売上、市場シェア（タイプⅠ、タイプⅡ） ・癌診断治療バイオマーカー技術プラットフォームの用途別分析/市場規模（） ・癌診断治療バイオマーカー技術プラットフォームの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・癌診断治療バイオマーカー技術プラットフォームの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Biomarker Technology Platforms for Cancer Diagnoses and Therapies market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biomarker Technology Platforms for Cancer Diagnoses and Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biomarker Technology Platforms for Cancer Diagnoses and Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biomarker Technology Platforms for Cancer Diagnoses and Therapies market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bruker Daltonics
Abbott
Agilent
BDI
OncoThyreon
Biomoda
Asuragen
Beckman Coulter
BioCurex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type I
Type II
Market Segment by Applications, can be divided into
Application I
Application II
Table of Contents
1 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Overview
1.1 Product Overview and Scope of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
1.2 Classification of Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Types
1.2.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Types in 2018
1.2.3 Type I
1.2.4 Type II
1.3 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market by Application
1.3.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Application I
1.3.3 Application II
1.4 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market by Regions
1.4.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Biomarker Technology Platforms for Cancer Diagnoses and Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Bruker Daltonics
2.1.1 Business Overview
2.1.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bruker Daltonics Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Agilent
2.3.1 Business Overview
2.3.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 BDI
2.4.1 Business Overview
2.4.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BDI Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 OncoThyreon
2.5.1 Business Overview
2.5.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 OncoThyreon Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biomoda
2.6.1 Business Overview
2.6.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biomoda Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Asuragen
2.7.1 Business Overview
2.7.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Asuragen Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.8 Beckman Coulter
2.8.1 Business Overview
2.8.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Beckman Coulter Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.9 BioCurex
2.9.1 Business Overview
2.9.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BioCurex Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Competition, by Players
3.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players Market Share
3.2.2 Top 10 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Players Market Share
3.3 Market Competition Trend
4 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Size by Regions
4.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Market Share by Regions
4.2 North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
5 North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries
5.1 North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
5.2 USA Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
6 Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries
6.1 Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
6.2 Germany Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
6.4 France Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries
7.1 Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
7.2 China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
7.5 India Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
8 South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries
8.1 South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
8.2 Brazil Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biomarker Technology Platforms for Cancer Diagnoses and Therapies by Countries
9.1 Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
10 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Segment by Type
10.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Forecast by Type (2019-2024)
10.3 Type I Revenue Growth Rate (2014-2024)
10.4 Type II Revenue Growth Rate (2014-2024)
11 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Segment by Application
11.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Application (2014-2019)
11.2 Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Forecast by Application (2019-2024)
11.3 Application I Revenue Growth (2014-2019)
11.4 Application II Revenue Growth (2014-2019)
12 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Size Forecast (2019-2024)
12.1 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Size Forecast (2019-2024)
12.2 Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Forecast by Regions (2019-2024)
12.3 North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
12.6 South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Picture
Table Product Specifications of Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies and Revenue (Million USD) Market Split by Product Type
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Types in 2018
Figure Type I Picture
Figure Type II Picture
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Application (2014-2024)
Figure Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Applications in 2018
Figure Application I Picture
Figure Application II Picture
Table Global Market Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Table Bruker Daltonics Basic Information, Manufacturing Base and Competitors
Table Bruker Daltonics Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Bruker Daltonics Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Abbott Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Agilent Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table BDI Basic Information, Manufacturing Base and Competitors
Table BDI Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table BDI Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table OncoThyreon Basic Information, Manufacturing Base and Competitors
Table OncoThyreon Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table OncoThyreon Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Biomoda Basic Information, Manufacturing Base and Competitors
Table Biomoda Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Biomoda Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Asuragen Basic Information, Manufacturing Base and Competitors
Table Asuragen Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Asuragen Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table Beckman Coulter Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table BioCurex Basic Information, Manufacturing Base and Competitors
Table BioCurex Biomarker Technology Platforms for Cancer Diagnoses and Therapies Type and Applications
Table BioCurex Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Players (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Players (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Players in 2017
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Players in 2018
Figure Global Top 5 Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share in 2018
Figure Global Top 10 Players Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share in 2018
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Regions (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Regions in 2018
Figure North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
Table North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries in 2018
Figure USA Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Canada Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Mexico Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries in 2018
Figure Germany Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure UK Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure France Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Russia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Italy Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries in 2018
Figure China Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Japan Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Korea Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure India Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Countries (2014-2019)
Table South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries in 2018
Figure Brazil Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Argentina Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Colombia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure UAE Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Egypt Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure Nigeria Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Figure South Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue and Growth Rate (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) by Type (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Type (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Type (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Type in 2019
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Forecast by Type (2019-2024)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Share Forecast by Type (2019-2024)
Figure Global Type I Revenue Growth Rate (2014-2019)
Figure Global Type II Revenue Growth Rate (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue by Application (2014-2019)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Application (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Application (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Share by Application in 2019
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Forecast by Application (2019-2024)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Market Share Forecast by Application (2019-2024)
Figure Global Application I Revenue Growth Rate (2014-2019)
Figure Global Application II Revenue Growth Rate (2014-2019)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
Figure Europe Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
Figure South America Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Biomarker Technology Platforms for Cancer Diagnoses and Therapies Revenue Market Forecast (2019-2024)
世界の前立腺がんバイオマーカー市場：市場規模・現状・予測 Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. In 2018, the global Prostate Cancer Biomarker market size was xx million US$ …- 世界の精密がん治療市場：市場規模・現状・予測 Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalit…
- 世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …
- 世界の診断用バイオマーカー市場：市場規模・現状・予測 Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
- 世界の改装されたDNAシーケンスプラットフォーム市場：市場規模・現状・予測 In 2018, the global Refurbished DNA Sequencing Platforms market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Refurbished DNA Sequencing Platforms status, future forecast, growth opportunity, key ma…